Table 2.
Effects of casein glycomacropeptide on blood analysis data of weanling piglets (day 13).
| Item | Control group | K88 challenged group | CGMP treated group | P-value |
|---|---|---|---|---|
| SA, mmol/L | 3.80 ± 0.23a | 3.69 ± 0.18a | 4.70 ± 0.32b | 0.027 |
| DAO, U/mL | 13.84 ± 0.95a | 23.77 ± 0.84c | 19.30 ± 0.90b | 0.000 |
| D-Lactate, μmol/L | 20.47 ± 0.74a | 32.46 ± 1.38c | 24.64 ± 0.69b | 0.000 |
| Pig-MAP, mg/L | 23.07 ± 0.46a | 46.39 ± 1.86c | 27.63 ± 0.79b | 0.000 |
| SIgA, mg/g protein | 1.39 ± 0.10a | 7.15 ± 1.07b | 5.35 ± 1.08b | 0.001 |
Results are given as mean ± SEM.
CGMP = casein glycomacropeptide; SA = sialic acid; DAO = diamine oxidase; Pig-MAP = pig major acute-phase protein; SIgA = secretory immunoglobulin A.
a,b,cDifferent superscript letters within a row represent statistically significant differences among groups (P < 0.05).